Frequency of sars-cov-2 infection and covid-19 vaccine uptake and protection among Syrian refugees: covid-19 vaccine among Syrian refugees

Basit Öğe Kaydı
dc.authorid0000-0001-6744-1343
dc.contributor.authorAltaş, Zeynep Meva
dc.contributor.authorSezerol, Mehmet Akif
dc.date.accessioned2024-06-27T05:41:13Z
dc.date.available2024-06-27T05:41:13Z
dc.date.issued2024
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Bilimleri Enstitüsü, Epidemiyoloji Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Halk Sağlığı Ana Bilim Dalı
dc.description.abstractIt is aimed to examine the frequency of COVID-19 disease, the rates of COVID-19 vaccination and the vaccine effectiveness (VE) among Syrian refugees. It is a retrospective cohort study. Syrian refugees aged 18 years and above registered to a family health center in Sultanbeyli district in Istanbul were included. Vaccine effectiveness were calculated for both Pfizer BioN-Tech and CoronaVac (Sinovac) vaccines. The data of 2586 Syrian people was evaluated in the study. The median age of the participants was 34.0 years (min:18.0; max: 90.0). Of the participants 58.4% (n = 1510) were female, 41.6% (n = 1076) were male. In our study of the refugees 15.7% had history of COVID-19 infection. Refugees having full vaccination with Biontech and Sinovac have a significantly lower COVID-19 infection rate than those without vaccination (HR = 8.687; p < 0.001). Adjusted VE for Biontech, Sinovac, and both were 89.2% (95.0% CI:83.3–93.1), 81.2% (95.0% CI:48.72–93.1) and 88.5% (95.0% CI:82.7–92.3), respectively. The results of the study highlight the importance of vaccinations against COVID-19 pandemic, since both vaccines were highly protective in refugees.
dc.identifier.citationAltaş, Z. M. ve Sezerol, M. A. (2024). Frequency of sars-cov-2 infection and covid-19 vaccine uptake and protection among Syrian refugees: covid-19 vaccine among Syrian refugees. BMC Infectious Diseases, 24(1). http://dx.doi.org/10.1186/s12879-024-09460-4
dc.identifier.doi10.1186/s12879-024-09460-4
dc.identifier.issn1471-2334
dc.identifier.issue1
dc.identifier.pmid38851672
dc.identifier.scopus2-s2.0-85195533560
dc.identifier.scopusqualityQ1
dc.identifier.urihttp://dx.doi.org/10.1186/s12879-024-09460-4
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12653
dc.identifier.volume24
dc.identifier.wos001244003200002en_US
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorSezerol, Mehmet Akif
dc.language.isoen
dc.relation.ispartofBMC Infectious Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19 Infection
dc.subjectRefugee
dc.subjectSyrian
dc.subjectVaccination
dc.subjectVaccine Effectiveness
dc.titleFrequency of sars-cov-2 infection and covid-19 vaccine uptake and protection among Syrian refugees: covid-19 vaccine among Syrian refugees
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Sezerol-Mehmet Akif-2024.pdf
Boyut:
1.23 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu